NCT05714878Completed
Multimodal Prehabilitation for Resectable Gastric Cancer
Multimodal Prehabilitation for Patients With Resectable Gastric Cancer: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 10 May 2024
Brief summary (registry, in English)
Surgical resection is the mainstay for gastric cancer. Surgical stress response, like insulin resistance and catabolism, is inevitable and is a risk factor for postoperative outcome. To cope with this stress, the enhanced recovery protocol has been proposed and successfully implemented in clinical practice. Recently, prehabilitation have attracted increasingly attention, which is the preoperative part of enhanced recovery pathway. Prehabtilitation are bundles of evidenced elements in order to improve patient's functional capacity. Patients with gastric cancer are usually suffered from nutritional risk, anxiety and frailty. In this trial, we investigate whether multimodal prehabilitation (exercise, nutrition and psychological support) could improve patient's functional status to better tolerate surgical trauma.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 70 (actual)
- First submitted
- 26 Jan 2023
- Start date
- 22 Mar 2023
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Chinese PLA General Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT05714878
What you commit to
- Study type: Interventional
- Participants enrolled: 70
- From 22 Mar 2023 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving immunosuppressive therapy;
Other illness
- Gastric stump cancer or combined with other malignances;
- Inability to swallow, with gastrostomy, or inability to move because of orthopedic disease or neuromuscular disease;
- Psychiatric disorders, COPD, end-stage hepatic or renal disease, uncontrolled cardiac arhythmia or uncontrolled hypertention;
- Emergency surgery because of tumor bleeding or tumor perforation;
Other
- NYHA III, NYHA IV;
Who the study is looking for
- Pathologically confirmed gastric cancer, clinical I-III TNM stage (AJCC 8th edition);
- Will receive curative-intent surgery;
- Life expectance \> 6 months;
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chinese PLA General Hospital First Medical Center Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.